Benutzer: Gast  Login
Weniger Felder
Einfache Suche
Titel:

Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis.

Dokumenttyp:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Article
Autor(en):
Hauschild, A; Weichenthal, M; Balda, BR; Becker, JC; Wolff, HH; Tilgen, W; Schulte, KW; Ring, J; Schadendorf, D; Lischner, S; Burg, G; Dummer, R
Abstract:
PURPOSE: Low-dose interferon alfa (IFNalpha) has been shown to have limited effects in the adjuvant treatment of patients with intermediate- and high-risk primary melanoma. We hypothesized that a combination regimen with low-dose interleukin-2 (IL-2) may improve survival prospects in these patients. PATIENTS AND METHODS: After wide excision of primary melanoma without clinically detectable lymph node metastasis (pT3 to 4, cN0, M0), 225 patients from 10 participating centers were randomly assigne...     »
Zeitschriftentitel:
J Clin Oncol
Jahr:
2003
Band / Volume:
21
Heft / Issue:
15
Seitenangaben Beitrag:
2883-8
Sprache:
eng
Volltext / DOI:
doi:10.1200/JCO.2003.07.116
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/12885805
Print-ISSN:
0732-183X
TUM Einrichtung:
Klinik und Poliklinik für Dermatologie und Allergologie
 BibTeX